# TAUVID

NDC: 0002-1220
Generic name: Flortaucipir F-18
Labeler / Manufacturer: Eli Lilly and Company
Product type: HUMAN PRESCRIPTION DRUG
Marketing category: New Drug Application (innovator)
Dosage form: INJECTION, SOLUTION
Routes: INTRAVENOUS
Marketing started: 20220701

FDA application: NDA212123

## Active ingredients

- FLORTAUCIPIR F-18: 100 mCi/mL

## Pharmacological class

—

## External sources

- openFDA: https://api.fda.gov/drug/ndc.json?search=product_ndc:"0002-1220"
- FDA NDC Directory: https://www.accessdata.fda.gov/scripts/cder/ndc/dsp_searchresult.cfm?p_ndc=0002-1220
- DailyMed: https://dailymed.nlm.nih.gov/dailymed/lookup.cfm?setid=b483abad-5230-462a-adfb-1a65160f01d0